ISIN | LU0950592369 |
---|---|
Valor Number | 21799651 |
Bloomberg Global ID | |
Fund Name | JSS Equity - Europe C EUR acc |
Fund Provider |
J. Safra Sarasin Investmentfonds AG
Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com |
Fund Provider | J. Safra Sarasin Investmentfonds AG |
Representative in Switzerland |
J. Safra Sarasin Investmentfonds AG Basel Phone: +41 58 317 44 00 |
Distributor(s) |
Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the fund is long-term capital appreciation through a Europewide, diversified investment in equities. |
Peculiarities |
Current Price * | 129.01 EUR | 03.09.2025 |
---|---|---|
Previous Price * | 127.90 EUR | 02.09.2025 |
52 Week High * | 135.35 EUR | 27.09.2024 |
52 Week Low * | 111.61 EUR | 09.04.2025 |
NAV * | 129.01 EUR | 03.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 42,505,846 | |
Unit/Share Assets *** | 530,246 | |
Trading Information SIX |
YTD Performance | +2.88% |
31.12.2024 - 03.09.2025
31.12.2024 03.09.2025 |
---|---|---|
YTD Performance (in CHF) | +2.60% |
31.12.2024 - 03.09.2025
31.12.2024 03.09.2025 |
1 month | +1.69% |
04.08.2025 - 03.09.2025
04.08.2025 03.09.2025 |
3 months | -0.32% |
03.06.2025 - 03.09.2025
03.06.2025 03.09.2025 |
6 months | -3.27% |
03.03.2025 - 03.09.2025
03.03.2025 03.09.2025 |
1 year | -3.90% |
03.09.2024 - 03.09.2025
03.09.2024 03.09.2025 |
2 years | +6.23% |
04.09.2023 - 03.09.2025
04.09.2023 03.09.2025 |
3 years | +19.28% |
05.09.2022 - 03.09.2025
05.09.2022 03.09.2025 |
5 years | +33.51% |
03.09.2020 - 03.09.2025
03.09.2020 03.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 4.31% | |
---|---|---|
ASML Holding NV | 4.26% | |
Allianz SE | 4.11% | |
Eurofins Scientific SE | 3.56% | |
Bankinter SA | 3.55% | |
Nordea Bank Abp | 3.49% | |
TotalEnergies SE | 3.37% | |
Amadeus IT Group SA | 3.31% | |
KONE Oyj Class B | 3.30% | |
Unilever PLC | 3.30% | |
Last data update | 31.07.2025 |
TER | 1.37% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.15% |
Ongoing Charges *** | 1.35% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |